These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23274668)

  • 21. Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication.
    Wang D; Iera J; Baker H; Hogan P; Ptak R; Yang L; Hartman T; Buckheit RW; Desjardins A; Yang A; Legault P; Yedavalli V; Jeang KT; Appella DH
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6893-7. PubMed ID: 19896372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
    Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
    Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.
    Gao G; Wu X; Zhou J; He M; He JJ; Guo D
    J Biol Chem; 2013 May; 288(20):14297-14309. PubMed ID: 23569210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel compounds against Tat-mediated human immunodeficiency virus-1 transcription by high-throughput functional screening assay.
    Shin Y; Kim HG; Park CM; Choi MS; Kim DE; Choi BS; Kim K; Yoon CH
    Biochem Biophys Res Commun; 2020 Mar; 523(2):368-374. PubMed ID: 31866007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
    Garber ME; Wei P; KewalRamani VN; Mayall TP; Herrmann CH; Rice AP; Littman DR; Jones KA
    Genes Dev; 1998 Nov; 12(22):3512-27. PubMed ID: 9832504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W; Pitha PM
    Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.
    Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex.
    Schulze-Gahmen U; Hurley JH
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12973-12978. PubMed ID: 30514815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
    Narayan V; Ravindra KC; Chiaro C; Cary D; Aggarwal BB; Henderson AJ; Prabhu KS
    J Mol Biol; 2011 Jul; 410(5):972-83. PubMed ID: 21763500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of HIV-1 Tat-mediated transactivation.
    Richter SN; Palù G
    Curr Med Chem; 2006; 13(11):1305-15. PubMed ID: 16712471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex.
    D'Orso I; Frankel AD
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3101-6. PubMed ID: 19223581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking HIV replication by targeting Tat protein.
    Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T
    Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing the formation of positive transcription elongation factor b by human cyclin T1-binding RNA aptamer for anti-HIV transcription.
    Um HJ; Kim M; Lee SH; Kim YH
    AIDS; 2012 Aug; 26(13):1599-605. PubMed ID: 22569018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
    Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
    Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.